glp 1 advantages Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action GLP-1 Drugs & What They
Description
Weight management shortcuts equal short-term rewards
The aim of this review is to explore and propose possible mechanisms through which GLP-1RAs may contribute to gallbladder disease and to evaluate the current clinical evidence on the incidence and severity of gallbladder-related adverse events in patients undergoing GLP-1RAs therapy
Table 3 Hazard Ratios for MOF in subgroup and sensitivity analyses
Mild stomach discomfort
